Jean‐Christophe Jullian
Papers
1
Total Citations
20
H-Index
1
About
Jean-Christophe Jullian is a pioneering researcher at the intersection of cardiac biology and drug discovery, whose work centers on mitochondrial dysfunction in heart failure. His most cited study, "A Cardiac-Specific Robotized Cellular Assay Identified Families of Human Ligands as Inducers of PGC-1α Expression and Mitochondrial Biogenesis" (2012, 20 citations), exemplifies his innovative approach. In this landmark work, Jullian developed a high-throughput robotic cellular assay to screen for compounds that restore PGC-1α—a critical transcriptional coactivator for mitochondrial energy metabolism that is downregulated in failing hearts. By identifying families of human ligands capable of inducing PGC-1α expression and mitochondrial biogenesis, he opened new therapeutic avenues for reversing the metabolic deficits underlying heart failure. This contribution not only advanced our understanding of cardiac energetics but also demonstrated a powerful methodology for drug discovery in cardiovascular disease. Though his citation count is modest, Jullian’s targeted, translational work has laid essential groundwork for developing treatments that target mitochondrial health, making him a key figure in the quest to combat heart failure through metabolic modulation.
Research Focus
Key Achievements
Top Papers
- 1